List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 11 studies with search of: Open Studies | "Coxsackievirus Infections"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers
Conditions: Melanoma;   Breast Cancer;   Prostate Cancer
Intervention: Drug: CVA21
2 Recruiting A Study of the Intratumoural Administration of CAVATAK to Head and Neck Cancer Patients
Condition: Head and Neck Cancer
Intervention: Biological: Coxsackievirus A21
3 Recruiting A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
Condition: The Study Focused on the Safety of Inactivated EV71 Vaccine (Human Diploid Cell) Against Hand, Foot and Mouth Disease in Chinese Children and Infants
Interventions: Biological: 160Eu/0.5ml in infants (6-11 months old);   Biological: 320Eu/0.5ml in infants (6-11 months old);   Biological: 640Eu/0.5ml in infants (6-11 months old);   Biological: 1280Eu/0.5ml (without adjuvant) in infants (6-11 months old);   Biological: 0Eu/0.5ml in infants (6-11 months old);   Biological: 160Eu/0.5ml in infants (12-23 months old);   Biological: 320Eu/0.5ml in infants (12-23 months old);   Biological: 640Eu/0.5ml in infants (12-23 months old);   Biological: 1280Eu/0.5ml (without adjuvant) in infants (12-23 months old);   Biological: 0Eu/0.5ml in infants (12-23 months old);   Biological: 160Eu/0.5ml in children (24 months-5 years old);   Biological: 320Eu/0.5ml in children (24 months-5 years old);   Biological: 640Eu/0.5ml in children (24 months-5 years old);   Biological: 1280Eu/0.5ml (without adjuvant) in children (24 months-5 years old);   Biological: 0Eu/0.5ml in children (24 months-5 years old)
4 Recruiting A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Other: Western therapy;   Other: Reduning Injection;   Other: Reduning Injection plus western therapy
5 Recruiting A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Other: Western therapy;   Drug: Xiyanping Injection;   Drug: Xiyanping Injection with western medicine
6 Recruiting A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Other: Western therapy;   Drug: TCM Syndrome Differentiation and Treatment;   Other: Western therapy plus TCM treatment
7 Recruiting A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months
Conditions: Hand, Foot and Mouth Disease;   Herpangina;   Other EV71-associated Diseases
Interventions: Biological: inactivated vaccine (Vero Cell) against EV71;   Biological: 0/0.5ml placebo
8 Recruiting An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
Condition: Hand, Foot and Mouth Disease
Interventions: Biological: 400U /0.5ml EV71 vaccine;   Biological: 0/0.5ml placebo
9 Recruiting A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
Condition: Hand, Foot and Mouth Disease
Interventions: Drug: Herbal concentrate-granules plus western therapy;   Drug: Reduning Injection plus western therapy;   Drug: Western therapy
10 Recruiting A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and Infants
Condition: The Study Focused on the Safety of Inactivated EV71 Vaccine (Human Diploid Cell) Against Hand, Foot and Mouth Disease in Chinese Adults, Children and Infants.
Interventions: Biological: 160Eu/0.5ml in adults;   Biological: 320Eu/0.5ml in adults;   Biological: 640Eu/0.5ml in adults;   Biological: 1280Eu/0.5ml (without adjuvant) in 12 adults;   Biological: 0Eu/0.5ml in adults;   Biological: 160Eu/0.5ml in children;   Biological: 320Eu/0.5ml in children;   Biological: 640Eu/0.5ml in children;   Biological: 1280Eu/0.5ml (without adjuvant) in children;   Biological: 0Eu/0.5ml in children;   Biological: 160Eu/0.5ml in infants;   Biological: 320Eu/0.5ml in infants;   Biological: 640Eu/0.5ml in infants;   Biological: 1280Eu/0.5ml (without adjuvant) in infants;   Biological: 0Eu/0.5ml in infants
11 Recruiting A Study of Intratumoral CAVATAK in Patients With Stage IIIc and Stage IV Malignant Melanoma
Condition: Malignant Melanoma
Intervention: Biological: CAVATAK (Coxsackievirus A21, CVA21)

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services